Skip to main content
. 2016 Nov 16;105(1):151–158. doi: 10.3945/ajcn.116.140780

TABLE 5.

Plasma measures of glucose, insulin, TGs, TNF-α, and IL-6 in participants in long-chain n–3 PUFA and placebo groups participating in an 18-wk resistance exercise intervention1

Placebo
Long-chain n–3 PUFA
Men (n = 11)
Women (n = 9)
Men (n = 13)
Women (n = 12)
Baseline 18 wk Baseline 18 wk Baseline 18 wk Baseline 18 wk
Glucose, mmol/L 5.33 ± 0.489 5.14 ± 0.34 6.07 ± 1.44 6.21 ± 1.64 5.21 ± 0.48 5.32 ± 0.64 5.80 ± 1.12 5.49 ± 1.20
TGs, mmol/L 0.86 ± 0.22 0.89 ± 0.32 1.29 ± 0.87 1.03 ± 0.32 1.00 ± 0.49 0.84 ± 0.34 0.88 ± 0.27 0.69 ± 0.16
Insulin, mU/mL 6.11 ± 2.66 5.71 ± 2.52 6.96 ± 4.67 6.02 ± 3.18 7.44 ± 4.91 7.78 ± 5.12 5.33 ± 3.04 5.5 ± 3.83
IL-6, pg/mL 1.34 ± 0.66 0.88 ± 0.24 1.77 ± 1.11 1.96 ± 1.02 1.32 ± 1.17 1.25 ± 0.75 1.63 ± 2.24 1.43 ± 1.96
TNF-α, pg/mL 4.91 ± 2.46 4.62 ± 2.05 4.81 ± 2.13 4.67 ± 1.89 4.95 ± 1.99 4.60 ± 1.73 5.27 ± 2.35 5.15 ± 2.21
EPA, % total lipids 1.44 ± 0.97 1.50 ± 1.33 1.47 ± 0.71 1.74 ± 0.50 1.47 ± 0.58 4.32 ± 1.64* 1.35 ± 0.79 4.68 ± 2.40*
DHA, % total lipids 5.16 ± 1.18 5.26 ± 1.40 5.18 ± 0.81 5.82 ± 0.62 5.89 ± 0.77 6.40 ± 0.68* 5.54 ± 1.95 6.52 ± 0.97*
1

All values are means ± SDs, P < 0.05. The data at 18 wk were compared via an ANOVA for group, sex, and sex-by-group interaction effects with baseline values of the outcome measure as a covariate. *Significant group effect with the baseline-adjusted 18-wk value higher in the long-chain n–3 PUFA groups than in their respective placebo groups. TG, triglyceride.